RankingsPricing
  1. JP-listed companies
  2. Daito Pharmaceutical Co., Ltd.
  3. Financials
  4. Gross profit

Daito Pharmaceutical Co., Ltd.【JP:4577】

Market cap
¥41B
P/E ratio
17.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
May 31, 20258,637-12.22%
May 31, 20249,839-4.76%
May 31, 202310,331-9.84%
May 31, 202211,458+6.11%
May 31, 202110,798+13.92%
May 31, 20209,479+9.31%
May 31, 20198,671+6.91%
May 31, 20188,111+4.62%
May 31, 20177,752+6.69%
May 31, 20167,266+2.80%
May 31, 20157,068

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)